Pharmacological intervention requires a careful review of fracture risk and in the absence of contraindications, the benefits of drug therapy are far greater than the potential risk of therapy. To read more about osteoporosis management guidelines, potential drug therapies, and drug-related adverse events of osteoporosis therapy visit the links below with valuable patient information:

Osteoporosis in Menopause Guidelines:

Drug-Related Adverse Events of Osteoporosis Therapy: https://www.boneresearch.ca/wp-content/uploads/DrugSE2016.pdf

Forteo: https://www.forteo.com/what-is-forteo

Prolia: https://www.prolia.com/how-prolia-works/how-prolia-works

Evenity: https://www.evenity.com/why-evenity/how-evenity-works

ONJ Brochure: https://osteoporosis.ca/wp-content/uploads/ONJ-Pamphlet-Mar16-1.pdf

Osteoporosis in Menopause